People - Staff
Paul-Howard

Senior Fellow & Director, Health Policy, Manhattan Institute

Dr. Paul Howard

Paul Howard is a senior fellow at the Manhattan Institute and director of health policy. He is a contributor to The Apothecary, the Forbes blog on health care policy and entitlement reform, and a regular columnist for The Morning Consult. Howard has written on a wide variety of medical-policy issues, including FDA reform, biopharmaceutical innovation, […]

Paul Howard is a senior fellow at the Manhattan Institute and director of health policy. He is a contributor to The Apothecary, the Forbes blog on health care policy and entitlement reform, and a regular columnist for The Morning Consult.

Howard has written on a wide variety of medical-policy issues, including FDA reform, biopharmaceutical innovation, consumer-driven health care, and Medicare and Medicaid reform. He is often quoted on health care issues, and his work has appeared in such publications as Bloomberg View, Wall Street Journal, National Affairs, USA Today, RealClearPolitics, New York Post, Investor’s Business Daily,Health Affairs, and FoxNews.com. He is a member of MI’s Project FDA.

Howard was part of the health care policy advisory group for Mitt Romney’s 2012 presidential campaign, has testified twice before Congress, and, in 2013 and 2014, served on an expert panel as a judge for Celgene’s Innovation Impact Awards. He joined MI in 2000, as deputy director of its Center for Legal Policy, where he edited research papers, managed legal policy analyses, and organized conferences. He holds a B.A. from the College of the Holy Cross and a Ph.D. in political science from Fordham University.

More from Concordia

Important Notice Regarding Fraudulent Website

We have identified a website operating under www.theconcordiasummit.org that is impersonating Concordia and copying our brand, language, and images. This site is not affiliated with Concordia. Our only official website is www.concordia.net.

If you have shared personal or payment information with the fraudulent site, please contact us immediately at enquiries@concordia.net

We are actively working to have the site removed.